Stempeutics plans to launch Stempeutron in India by mid 2015 pharmabiz.com The product which is currently undergoing the last stage of phase 2 clinical trial across the country for the indication of critical limb ischemia (CLI), osteoarthritis (OA) and liver sclerosis is expected to enter phase 3 trial by early 2013. Three ... |
